194 related articles for article (PubMed ID: 22525502)
1. [Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].
Sun HY; Li Y; Guo K; Kang XN; Sun C; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):904-7. PubMed ID: 22525502
[TBL] [Abstract][Full Text] [Related]
2. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
[TBL] [Abstract][Full Text] [Related]
4. [Relative analysis of OPN and its related signal molecules in hepatocellular carcinoma].
Zhang L; Li HY; Yin XL; Xu YP; Chen Y; Xie XY; Shen YF; Ye QH; Ren ZG
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):48-51. PubMed ID: 21272459
[TBL] [Abstract][Full Text] [Related]
5. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sun BS; Dong QZ; Ye QH; Sun HJ; Jia HL; Zhu XQ; Liu DY; Chen J; Xue Q; Zhou HJ; Ren N; Qin LX
Hepatology; 2008 Dec; 48(6):1834-42. PubMed ID: 18972404
[TBL] [Abstract][Full Text] [Related]
7. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between CD44 expression or glycosylation and hepatocellular carcinoma metastasis].
Chen BL; Guo K; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):898-903. PubMed ID: 22525501
[TBL] [Abstract][Full Text] [Related]
9. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
11. [Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].
Cui BK; Zhang CQ; Zhang Y; Yuan YF; Zhang YQ; Shi M; Chen MS; Li SP; Li JQ
Ai Zheng; 2006 Jul; 25(7):876-9. PubMed ID: 16831281
[TBL] [Abstract][Full Text] [Related]
12. Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis.
Zhou Q; Huang T; Wang YF; Zhou XB; Liang LJ; Peng BG
Chin Med J (Engl); 2011 Nov; 124(22):3746-51. PubMed ID: 22340235
[TBL] [Abstract][Full Text] [Related]
13. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma].
Song LJ; Ye SL; Wang KF; Weng YQ; Liang CM; Sun RX; Zhao Y; Liu YK; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):428-31. PubMed ID: 15975276
[TBL] [Abstract][Full Text] [Related]
15. [Expression of CXCR3 in hepatocellular carcinoma].
Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
[TBL] [Abstract][Full Text] [Related]
16. [Expression of osteopontin mRNA and its protein in colorectal cancer and liver metastatic tissues].
Ding L; Zheng S; Cao J
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):970-3. PubMed ID: 12181091
[TBL] [Abstract][Full Text] [Related]
17. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
[TBL] [Abstract][Full Text] [Related]
18. [Differential analysis of tyrosine-phosphorylated proteins in human hepatocellular carcinoma cell lines with different metastasis potentials].
Zhang LJ; Cui JF; Liu YK; Zhu YS; Song HY; Shen HL; Feng JT; Dai Z; Chen J; Sun RX
Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):436-9. PubMed ID: 15975278
[TBL] [Abstract][Full Text] [Related]
19. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
Dai Z; Liu YK; Cui JF; Shen HL; Chen J; Sun RX; Zhang Y; Zhou XW; Yang PY; Tang ZY
Proteomics; 2006 Nov; 6(21):5857-67. PubMed ID: 17068759
[TBL] [Abstract][Full Text] [Related]
20. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]